Rhinoscleroma overview: Difference between revisions
m Changes made per Mahshid's request |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
'''Rhinoscleroma''' is a chronic [[granulomatous]] bacterial disease of the nose that can sometimes infect the [[upper respiratory tract]]. It most commonly affects the nasal cavity—the nose is involved in 95-100 per cent of cases—however, it can also affect the nasopharynx, larynx, trachea, and bronchi. | '''Rhinoscleroma''' is a chronic [[granulomatous]] bacterial disease of the nose that can sometimes infect the [[upper respiratory tract]]. It most commonly affects the nasal cavity—the nose is involved in 95-100 per cent of cases—however, it can also affect the nasopharynx, larynx, trachea, and bronchi. | ||
==Epidemiology and Demographics== | |||
Slightly more females than males are affected and patients are usually 10 to 30 years of age. Rhinoscleroma is considered a tropical disease and is mostly endemic to Africa and Central America, less common in the United States. | |||
==Natural History, Complications and Prognosis== | |||
Rhinoscleroma is not lethal in nature and is responsive to [[Tetracycline]] or [[Ciprofloxacin]]. However, if left untreated the disease can lead to sepsis, hemorrhage or other chronic conditions that can be fatal. | |||
==Medical Therapy== | |||
Rhinoscleroma is not lethal in nature and is responsive to [[Tetracycline]] or [[Ciprofloxacin]]. | |||
==References== | ==References== | ||
| Line 10: | Line 19: | ||
[[Category:Bacterium-related cutaneous conditions]] | [[Category:Bacterium-related cutaneous conditions]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 18:38, 18 September 2017
|
Rhinoscleroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhinoscleroma overview On the Web |
|
American Roentgen Ray Society Images of Rhinoscleroma overview |
|
Risk calculators and risk factors for Rhinoscleroma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Rhinoscleroma is a chronic granulomatous bacterial disease of the nose that can sometimes infect the upper respiratory tract. It most commonly affects the nasal cavity—the nose is involved in 95-100 per cent of cases—however, it can also affect the nasopharynx, larynx, trachea, and bronchi.
Epidemiology and Demographics
Slightly more females than males are affected and patients are usually 10 to 30 years of age. Rhinoscleroma is considered a tropical disease and is mostly endemic to Africa and Central America, less common in the United States.
Natural History, Complications and Prognosis
Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin. However, if left untreated the disease can lead to sepsis, hemorrhage or other chronic conditions that can be fatal.
Medical Therapy
Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin.